Global Death Receptor 5 (DR5) Antibody Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Death Receptor 5 (DR5) Antibody Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Death Receptor 5 (DR5) Antibody is an antibody specific for DR5 protein.
Death Receptor 5 (DR5) Antibody report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Death Receptor 5 (DR5) Antibody market is projected to reach US$ 894.4 million in 2029, increasing from US$ 394.6 million in 2022, with the CAGR of 12.4% during the period of 2024 to 2029. Demand from Flow Cytometry and ELISA are the major drivers for the industry.
DR5, also known as TRAIL-R2, is a member of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor family and is mainly expressed on the cell membrane. It plays a key role in the pathway of cell apoptosis. After combining with TRAIL, it triggers the signal transduction pathway and promotes the cell to enter the process of apoptosis, thus playing a role in the balance of cell survival and death. The application of DR5 antibody is helpful to study the expression of DR5 protein and its function in regulating apoptosis, especially in the research of tumor therapy, which has potential application prospects. By interfering with DR5 signaling, DR5 antibodies may be used as part of a therapeutic strategy to induce malignant tumor cells to enter apoptosis, providing a new direction for cancer treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Death Receptor 5 (DR5) Antibody market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Sino Biological, Inc.
ProSci Incorporated
CLOUD-CLONE CORP.
MyBiosource, Inc.
Rockland Immunochemicals, Inc.
Creative Biolabs
Cell Signaling Technology, Inc.
Thermo Fisher Scientific (China) Co., Ltd.
Bio-Techne
Biotium
Abcam
Bio X Cell
Abbiotec, Inc.
Wuhan Fine Biotech Co., Ltd.
Boster Biological Technology
Segment by Type
Monoclonal Antibody
Polyclonal Antibody
Flow Cytometry
ELISA
Western Blot
Immunoprecipitation
Immunofluorescence
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Death Receptor 5 (DR5) Antibody market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Death Receptor 5 (DR5) Antibody, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Death Receptor 5 (DR5) Antibody industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Death Receptor 5 (DR5) Antibody in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Death Receptor 5 (DR5) Antibody introduction, etc. Death Receptor 5 (DR5) Antibody Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Death Receptor 5 (DR5) Antibody market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Death Receptor 5 (DR5) Antibody report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Death Receptor 5 (DR5) Antibody market is projected to reach US$ 894.4 million in 2029, increasing from US$ 394.6 million in 2022, with the CAGR of 12.4% during the period of 2024 to 2029. Demand from Flow Cytometry and ELISA are the major drivers for the industry.
DR5, also known as TRAIL-R2, is a member of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor family and is mainly expressed on the cell membrane. It plays a key role in the pathway of cell apoptosis. After combining with TRAIL, it triggers the signal transduction pathway and promotes the cell to enter the process of apoptosis, thus playing a role in the balance of cell survival and death. The application of DR5 antibody is helpful to study the expression of DR5 protein and its function in regulating apoptosis, especially in the research of tumor therapy, which has potential application prospects. By interfering with DR5 signaling, DR5 antibodies may be used as part of a therapeutic strategy to induce malignant tumor cells to enter apoptosis, providing a new direction for cancer treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Death Receptor 5 (DR5) Antibody market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Sino Biological, Inc.
ProSci Incorporated
CLOUD-CLONE CORP.
MyBiosource, Inc.
Rockland Immunochemicals, Inc.
Creative Biolabs
Cell Signaling Technology, Inc.
Thermo Fisher Scientific (China) Co., Ltd.
Bio-Techne
Biotium
Abcam
Bio X Cell
Abbiotec, Inc.
Wuhan Fine Biotech Co., Ltd.
Boster Biological Technology
Segment by Type
Monoclonal Antibody
Polyclonal Antibody
Segment by Application
Flow Cytometry
ELISA
Western Blot
Immunoprecipitation
Immunofluorescence
Others
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Death Receptor 5 (DR5) Antibody market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Death Receptor 5 (DR5) Antibody, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Death Receptor 5 (DR5) Antibody industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Death Receptor 5 (DR5) Antibody in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Death Receptor 5 (DR5) Antibody introduction, etc. Death Receptor 5 (DR5) Antibody Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Death Receptor 5 (DR5) Antibody market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices